EUCTR2020-003879-18-PL进行中（未招募）1 期
Treatment of chronic hepatitis C in children aged 6 – 18 years using a pangenotypic direct-acting antiviral (sofosbuvir/velpatasvir)
Medical University of Warsaw0 个研究点目标入组 50 人开始时间: 2020年11月17日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •written, voluntary informed consent to participate in the study
- •diagnosis of chronic hepatitis C
- •age 6-18 years
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range: 50
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •refusal to consent to participate in the study
- •hypersensitivity to the active substance or excipients of the drug
- •no HCV RNA in blood serum in the presence of anti-HCV antibodies
- •pregnancy or breastfeeding
- •hepatitis B infection (active or past)
- •simultaneous intake of drugs that affect the interaction with active substances, including rosuvastatin or strong inhibitors of P-glycoprotein
- •active addiction to alcohol or intoxicants
研究者
相似试验
已完成
不适用
TREATMENT OF PATIENTS WITH CHRONIC HEPATITIS C (HCC) USING PEG-INTERFERON ALPHA 2B AND RIBAVIRINEPER-039-01SCHERING PLOUGH RESEARCH INSTITUTE,
进行中（未招募）
1 期
Four weeks treatment for chronic hepatitis C in patients under 50 years of age with no significant liver fibrosisEUCTR2017-005179-21-DKDepartment of infectious Diseases, Odense University Hospital227
终止
不适用
Post-marketing Surveillance of Children With Chronic Hepatitis C Treated With Intron A (Vial or Pen) and Rebetol (Study P04397)(TERMINATED)Hepatitis C, ChronicHepatitis CNCT00727077Merck Sharp & Dohme LLC3
已完成
不适用
Study on chronic hepatitis C treatment with interferon alpha, ribavirin and amantadine in naive patients.Chronic viral hepatitisInfections and InfestationsHepatitis CISRCTN74271466niversity Medical Centre Utrecht (UMCU) (Netherlands)390
已完成
2 期
A pilot phase II open-label study of oglufanide disodium in patients with chronic hepatitis CChronic hepatitis CInfection - Other infectious diseasesACTRN12607000418471Implicit Bioscience Pty Ltd17